1505 Adams Drive, Suite B2
15 articles with Avellino Labs
Avellino Launches AvaGen Nationwide as First Genetic Test to Quantify Keratoconus Risk and Presence of Corneal Dystrophies
Avellino Lab USA, Inc. (Avellino) today announced full nationwide availability in the U.S. of AvaGen™, The Genetic Eye Test, as the first genetic test that helps determine a patient’s risk of keratoconus and the presence of other corneal dystrophies.
Avellino USA announced the company in collaboration with Ulster University won the 2020 US-Ireland Research Innovation Award for Higher Education Institute/Research Centre for pioneering work in rare genetic eye diseases.
Avellino announced the appointment of three new members to its Board of Directors.
Avellino announced that the company has developed a novel multi-panel RT-PCR-based virus assay, AvellinoCoV2-Respiratory, which has been validated following the U.S. Food and Drug Administration’s Policy for Diagnostics Testing in Laboratories Certified to Perform High-Complexity Testing CLIA guidelines.
Partnership Focused In Short Term On COVID-19 Genetic Diagnostics and Solutions, Long Term Collaboration On Partner Diagnostics and Therapeutics
Avellino announced that the company has performed over 1-million genetic and molecular diagnostic tests.
Avellino Announces A.C.T.S. Program to Help Eye Care and Other Surgical Practices Protect Patients and Staff From COVID-19
Avellino announced the rollout of the new A.C.T.S. Program (Active Coronavirus Testing & Safety) designed to help ophthalmology and other elective surgery and procedure-oriented practices safely reopen and resume care while protecting patients and staff from COVID-19 virus transmission. Avellino Group Chairman Gene Lee said, “As states ease their shelte
Avellino announced that it has partnered with the OC Health Care Agency to launch the OC COVID-19 Testing Network.
Ultra-fast Genetic Test For COVID-19 Created By Bay Area Lab Avellino
Temporarily Suspending Production of the AvaGen™ Test For Keratoconus and Corneal Dystrophies
Avellino announced that its newly developed coronavirus diagnostic test has been validated pursuant to the policy for diagnostics testing during a public health emergency of the United States Food and Drug Administration pending the FDA’s independent review.
5/24/2019Biopharma companies from across the globe strengthen their leadership teams with key executive appointments.
5/3/2019Biopharma companies make changes to their C-suite leadership teams, with hires at uBiome, Enzyre, Sobi, Amylyx, Mission Therapeutics, and more.
Avellino Lab Commences Cross-Sectional Study Of The Prevalence Of TGFBI Corneal Dystrophies In A North American Population